Trial Now Recruiting: Monogenic Kidney Stone - Genetic Testing (NCT03305835)
WHY IT MATTERS
If you have a rare monogenic kidney stone disease, this trial could help identify the genetic cause of your condition and accelerate development of targeted treatments — and you can enroll now.
Researchers at Mayo Clinic are looking for 6,000 people with rare kidney stone diseases caused by a single gene mutation to join a study. The study will identify which specific genes and genetic changes cause these kidney stones. By understanding the genetics behind these stones, scientists hope to develop better treatments in the future.
NCT ID: NCT03305835 Status: RECRUITING Conditions: Rare Kidney Stone Diseases Enrollment: 6000 Sponsor: Mayo Clinic Summary: This study will attempt to identify the specific gene (coded in the DNA) and changes (mutations) within that gene that are the cause of monogenic kidney stone disease. This study will help researchers determine the characteristics of the stone disease associated with specific genes and mutations. This information may help develop more effective treatments for monogenic kidney stone diseases.
YOU CAN ACT ON THIS
If you have been diagnosed with a rare kidney stone disease or have a family history of unusual kidney stones, contact Mayo Clinic (reference NCT03305835) to learn if you qualify for enrollment.